PLA2G6 Antikörper

Produktnummer ABIN7191907

Produktdetails anti-PLA2G6 Antikörper

Target: PLA2G6 (Phospholipase A2, Group VI (Cytosolic, Calcium-Independent) (PLA2G6))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PLA2G6 Antikörper ist unkonjugiert

Applikation: ELISA, Immunohistochemistry (IHC)

Kreuzreaktivität: Human, Maus, Ratte

Aufreinigung: Antigen affinity purification

Immunogen: Synthetic peptide of Human PLA2G6

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: ELISA:1:2000-1:5000, IHC:1:15-1:50,

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: -20 °C, pH 7.4 PBS, 0.05 % Sodium azide, 40 % Glycerol

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu PLA2G6

Target: PLA2G6 (Phospholipase A2, Group VI (Cytosolic, Calcium-Independent) (PLA2G6))

Andere Bezeichnung: PLA2G6 (PLA2G6 Produkte)

Synonyme: zgc:77476 antikoerper, wu:fc06g09 antikoerper, PNPLA9 antikoerper, MGC83523 antikoerper, PLA2G6 antikoerper, BB112799 antikoerper, iPLA(2)beta antikoerper, iPLA2 antikoerper, iPLA2beta antikoerper, CaI-PLA2 antikoerper, GVI antikoerper, INAD1 antikoerper, IPLA2-VIA antikoerper, NBIA2 antikoerper, NBIA2A antikoerper, NBIA2B antikoerper, PARK14 antikoerper, PLA2 antikoerper, iPla2 antikoerper, phospholipase A2, group VI (cytosolic, calcium-independent) antikoerper, phospholipase A2 group VI antikoerper, phospholipase A2 group VI S homeolog antikoerper, 85/88 kDa calcium-independent phospholipase A2 antikoerper, phospholipase A2, group VI antikoerper, pla2g6 antikoerper, PLA2G6 antikoerper, pla2g6.S antikoerper, LOC100445065 antikoerper, Pla2g6 antikoerper

Hintergrund:

Background: The protein encoded by this gene is an A2 phospholipase, a class of enzyme that catalyzes the release of fatty acids from phospholipids. The encoded protein may play a role in phospholipid remodelling, arachidonic acid release, leukotriene and prostaglandin synthesis, fas-mediated apoptosis, and transmembrane ion flux in glucose-stimulated B-cells. Several transcript variants encoding multiple isoforms have been described, but the full-length nature of only three of them have been determined to date.

Aliases: 85 kDa calcium independent phospholipase A2 antibody, 85/88 kDa calcium-independent phospholipase A2 antibody, BB112799 antibody, CaI PLA2 antibody, CaI-PLA2 antibody, CaIPLA2 antibody, Calcium independent phospholipase A2 antibody, CTA-228A.2 antibody, Cytosolic calcium independent phospholipase A2 antibody, EC 3.1.1.4 antibody, Group VI phospholipase A2 antibody, Group VI, A antibody, GVI antibody, GVI PLA2 antibody, INAD1 antibody, Intracellular membrane associated calcium independent phospholipase A2 beta antibody, Intracellular membrane-associated calcium-independent phospholipase A2 beta antibody, iPLA(2)beta antibody, iPLA2 beta antibody, iPLA2-beta antibody, IPLA2-VIA antibody, iPLA2beta antibody, NBIA2 antibody, NBIA2A antibody, NBIA2B antibody, Neurodegeneration with brain iron accumulation 2 antibody, OTTHUMP00000199457 antibody, PARK14 antibody, Patatin like phospholipase domain containing 9 antibody, Patatin like phospholipase domain containing protein 9 antibody, Patatin-like phospholipase domain-containing protein 9 antibody, Phospholipase A2 calcium independent antibody, Phospholipase A2 calcium independent group VI A antibody, Phospholipase A2 group VI antibody, Phospholipase A2 group VI cytosolic calcium independent antibody, Phospholipase A2, group VI (cytosolic, calcium independent) antibody, PLA2 antibody, PLA2G6 antibody, PLPL9_HUMAN antibody, PNPLA9 antibody

UniProt: O60733

Pathways: Positive Regulation of Peptide Hormone Secretion